Clinical Trials

Overview Trusted Sites
Resources Find Support Support Groups News & Events News Feeds
Events Clinical Trials Open Studies Publications Editorial Articles
Research Articles
Review Articles Participate Share your experience

Medical Disclaimer

The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment.

Cavernous angioma

Cavernous hemangiomaCerebral cavernous malformation (CCM)Cavernoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials

Displaying 1-8 of 8 results.

Pattern and Management of Intracranial Cavernoma

Status: Not yet recruiting

Last Changed: Nov 29, 2019

First Received: Nov 29, 2019

Disease(s): Management of Intracranial Cavernous Hemangioma

Intervention(s): surgical excision of intracranial cavernoma

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Status: Recruiting

Last Changed: Sep 27, 2019

First Received: Aug 29, 2018

Disease(s): CCM, Cavernoma, Cerebral Cavernous Malformation, Cerebral Cavernous Malformations 1, Cerebral Cavernous Malformations 2, Cerebral Cavernous Malformations 3, Cavernous Angioma

Locations: The University of Chicago Medical Center, Chicago, Illinois, United States

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Status: Recruiting

Last Changed: Mar 10, 2020

First Received: Nov 11, 2015

Disease(s): Cerebral Cavernous Malformation

Intervention(s): Atorvastatin, Placebo

Locations: University of Chicago, Chicago, Illinois, United States

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Status: Recruiting

Last Changed: Dec 12, 2019

First Received: Jan 09, 2013

Disease(s): Cavernous Angioma, Familial, Cerebral Cavernous Malformations, Cerebral Cavernous Hemangioma

Locations: Barrow Neurological Institute, Phoenix, Arizona, United States
University of California, San Francisco, San Francisco, California, United States
University of Chicago, Medicine and Biological Sciences, Chicago, Illinois, United States
Boston Children's Hospital, Boston, Massachusetts, United States
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
... and 3 other locations.

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

Status: Recruiting

Last Changed: Sep 04, 2019

First Received: Sep 03, 2019

Disease(s): Cavernous Malformation, Cerebral, Cavernous Angioma, Cavernous Hemangioma, Cavernous Hemangioma of Brain, Seizures, Seizures, Epileptic, Epilepsy

Locations: Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Peking University International Hospital, Beijing, Beijing, China

Treat_CCM: Propranolol in Cerebral Cavernous Malformation

Status: Recruiting

Last Changed: Jan 23, 2020

First Received: Jul 17, 2018

Disease(s): Cerebral Cavernous Malformation

Intervention(s): Propranolol

Locations: IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy
IRCCS Centro Neurolesi "Bonino Pulejo", Messina, ME, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Mi, Italy
Fond. IRCCS Ist. Naz. Neurologico Carlo Besta, Milano, MI, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
... and 2 other locations.

Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.

Status: Recruiting

Last Changed: Mar 19, 2018

First Received: Mar 16, 2018

Disease(s): Cerebral Cavernous Malformations

Intervention(s): Surgery, Observation

Locations: The first affiliated hospital of fujian medical university, Fuzhou, Fujian, China

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

Status: Recruiting

Last Changed: Sep 20, 2019

First Received: Oct 27, 2016

Disease(s): Cerebral Cavernous Malformation, Intracerebral Hemorrhage

Locations: KangWon National University Hospital, Chuncheon, Kangwon, Korea, Republic of
HUMC-Chuncheon Sacred Heart Hospital, Chuncheon, Kanwon, Korea, Republic of
DongGuk University, Ilsan, Kyungkido, Korea, Republic of
Gyeongsang National University Hospital, Jinju, South Gyeongsang, Korea, Republic of
Jeju National University Hospital, Jeju, Korea, Republic of
... and 4 other locations.